Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Nov 30, 2025 | (Q2)Aug 31, 2025 | (Q1)May 31, 2025 | (FY)Feb 28, 2025 | (Q4)Feb 28, 2025 | (Q3)Nov 30, 2024 | (Q2)Aug 31, 2024 | (Q1)May 31, 2024 | (FY)Feb 29, 2024 | (Q4)Feb 29, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 10.75%622.41M | 14.12%617.88M | 14.87%599.92M | 15.07%2.2B | 14.65%575.04M | 15.51%562M | 14.78%541.43M | 15.37%522.26M | 16.60%1.91B | 15.93%501.57M |
| Cost of revenue | 33.54%120.28M | 27.28%115.36M | 14.76%116.31M | 10.16%598.18M | 8.19%91.14M | 3.69%90.07M | 11.99%90.63M | 20.18%101.35M | 9.61%543.01M | -67.99%84.24M |
| Gross profit | 6.40%502.13M | 11.47%502.53M | 14.90%483.62M | 17.02%1.6B | 15.95%483.9M | 18.08%471.93M | 15.35%450.8M | 14.27%420.91M | 19.62%1.37B | 146.26%417.34M |
| Operating expense | 0.95%354.02M | 18.75%376.19M | 35.63%358.06M | 25.09%958.23M | 16.21%261.98M | 23.03%350.69M | 40.36%316.8M | 11.85%264.01M | 29.16%766.03M | 495.77%225.43M |
| Staff costs | ---- | ---- | ---- | 13.28%45.22M | ---- | ---- | ---- | ---- | 13.73%39.92M | ---- |
| Depreciation and amortization | ---- | ---- | ---- | -7.74%35.7M | ---- | ---- | ---- | ---- | -7.59%38.7M | ---- |
| -Depreciation | ---- | ---- | ---- | -7.74%35.7M | ---- | ---- | ---- | ---- | -7.59%38.7M | ---- |
| Other operating expenses | 1.94%407.15M | 17.27%432.54M | 24.00%411.16M | 28.59%1.13B | 28.49%350.24M | 19.74%399.4M | 34.03%368.83M | 16.24%331.58M | 23.60%881.78M | 2,792.00%272.57M |
| Total other operating income | 9.06%53.13M | 8.31%56.35M | -21.42%53.1M | 32.00%256.57M | 87.21%88.26M | 0.40%48.71M | 5.14%52.03M | 37.29%67.57M | -1.49%194.37M | -2.92%47.14M |
| Operating profit | 22.16%148.11M | -5.72%126.34M | -19.98%125.55M | 6.77%644.32M | 15.64%221.92M | 5.78%121.24M | -18.84%133.99M | 18.58%156.9M | 9.37%603.45M | 45.79%191.91M |
| Net non-operating interest income (expenses) | 83.18%-3.06M | 66.08%-4.79M | -25.73%-606K | -187.94%-62.48M | -52.34%-19.41M | -471.96%-18.22M | -140.59%-14.12M | -20.80%-482K | -355.19%-21.7M | -598.79%-12.74M |
| Non-operating interest expense | -83.18%3.06M | -66.08%4.79M | 25.73%606K | 187.94%62.48M | 52.34%19.41M | 471.96%18.22M | 140.59%14.12M | 20.80%482K | 355.19%21.7M | 598.79%12.74M |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | -29.27%-19.62M | 1.29%-18.5M | -37.28%-15.92M | -312.25%-68.33M | -37.68%-22.82M | -15.18M | -18.74M | -11.59M | -16.58M | -16.58M |
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | ||||||||||
| Income before tax | 42.77%125.43M | 1.89%103.05M | -24.72%109.03M | -9.14%513.51M | 10.52%179.7M | -21.16%87.85M | -36.48%101.14M | 9.79%144.83M | 3.33%565.17M | 25.26%162.6M |
| Income tax | 35.95%35.04M | 2.80%30.82M | -18.04%31.48M | 1.23%142.9M | 11.57%48.73M | -0.43%25.78M | -23.22%29.98M | 18.01%38.41M | 9.18%141.16M | 26.70%43.68M |
| Net income | 45.61%90.38M | 1.51%72.23M | -27.13%77.55M | -12.60%370.61M | 10.13%130.97M | -27.44%62.07M | -40.79%71.16M | 7.10%106.41M | 1.52%424.02M | 24.73%118.92M |
| Net income continuous operations | 45.61%90.38M | 1.51%72.23M | -27.13%77.55M | -12.60%370.61M | 10.13%130.97M | -27.44%62.07M | -40.79%71.16M | 7.10%106.41M | 1.52%424.02M | 24.73%118.92M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 45.61%90.38M | 1.51%72.23M | -27.13%77.55M | -12.60%370.61M | 10.13%130.97M | -27.44%62.07M | -40.79%71.16M | 7.10%106.41M | 1.52%424.02M | 24.73%118.92M |
| Preferred stock dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| Other under preferred stock dividend | -1.43M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.63%10M | -3.24%4.96M |
| Net income attributable to common stockholders | 47.90%91.81M | 1.51%72.23M | -27.13%77.55M | -10.48%370.61M | 14.92%130.97M | -27.44%62.07M | -38.20%71.16M | 7.10%106.41M | 1.59%414.02M | 26.32%113.96M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 47.86%0.1798 | 1.51%0.1415 | -27.11%0.1519 | -10.48%0.7258 | 14.92%0.2565 | -27.40%0.1216 | -38.18%0.1394 | 7.09%0.2084 | 1.59%0.8108 | 26.32%0.2232 |
| Diluted earnings per share | 47.86%0.1798 | 1.51%0.1415 | -27.11%0.1519 | -10.48%0.7258 | 14.92%0.2565 | -27.40%0.1216 | -38.18%0.1394 | 7.09%0.2084 | 1.59%0.8108 | 26.33%0.2232 |
| Dividend per share | -8.77%0.13 | 3.57%0.145 | 0 | 14.14%0.2825 | 0 | 0.00%0.1425 | 33.33%0.14 | 0 | 13.79%0.2475 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.